Lilly U.S.A. hires singer Angie Stone to promote diabetes awareness
BIRMINGHAM, Ala. A drug maker is sponsoring an initiative to raise awareness of diabetes among African-Americans and has hired a Grammy-nominated singer to help promote it.
Lilly U.S.A., a subsidiary of Indianapolis-based Eli Lilly & Co., has enlisted Angie Stone to go to Birmingham, Ala., to help promote the Fearless African-Americans Connected and Empowered Diabetes initiative and encourage those living with diabetes to take control of their disease, Lilly announced Monday.
The event will take place Saturday from 1 p.m. to 5 p.m. at the More Than Conquerer Faith Church, at 1327 Dennison Ave., Birmingham, AL 35211. The free event will feature “Diabetes 101” educational materials and access to certified diabetes educators who can answer questions about management of the disease, and interactive experiential zone featuring resources from supporting community health organizations and a first-hand testimonial from Stone about her experience managing diabetes, as well as live performances of songs from her latest album.
Stone has been traveling to cities around the country since 2007 as the national spokeswoman for the F.A.C.E. Diabetes initiative.
Baby Vibe unveils gum massaging product for teething children
THOUSAND OAKS, Calif. Baby Vibe on Monday announced its new option for parents seeking teething relief for their children, the JeJe Teether, a product that creates a vibrating sensation that massages aching gums and eases the process of cutting teeth. The vibrations last seven minutes before JeJe Teether switches off automatically.
“The vibration produced by the JeJe Teether actually stimulates gum tissue and facilitates the tooth breakthrough process quite naturally,” stated Mario Gonzalez, co-founder of Baby Vibe. “So the function of the JeJe Teether is twofold: It relieves the pain and shortens the window in which the baby can experience pain.”
Perrigo begins shipping OTC ibuprofen and diphenhydramine citrate tablets
ALLEGAN, Mich. Perrigo on Friday announced that the company has begun shipping over-the-counter ibuprofen and diphenhydramine citrate tablets, 200/38 mg. The product will be marketed under store brand labels and is comparable to Wyeth Consumer Healthcare’s Advil PM tablets, 200/38 mg, indicated as a pain reliever/nighttime sleep-aid.
Estimated brand sales for the product for the last 12 months ending Sept. 28 were $70 million, according to Perrigo estimates.